SCHEMBL3831388

SCHEMBL3831388

CCOc1ccc2c(c1OCC)C(=O)OC21c2ccccc2Oc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.55
ALDH1A1 P00352 8/20 0.40
MEN1 O00255 4/20 0.40
MAPT P10636 4/20 0.40
KMT2A Q03164 4/20 0.40
HTT P42858 2/20 0.40
USP2 O75604 2/20 0.40
LMNA P02545 1/20 0.40
FTO Q9C0B1 2/20 0.38
HPGD P15428 2/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
SMAD3 P84022 1/20 0.38
PRMT1 Q99873 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 5/20 0.36
BRCA1 P38398 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7088951 0.87 CYP3A4 (0.49) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL5176015 0.86 FTO (0.51) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL5532838 0.81 NPC1 (0.44) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL1524853 0.75 PRKCA (0.47) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL7864064 0.75 FTO (0.55) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL658739 0.73 CYP3A4 (0.40) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL7542402 0.73 CYP3A4 (0.61) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL8757874 0.73 FTO (0.41) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL10709421 0.72 CYP3A4 (0.41) CYP3A4ALDH1A1MEN1MAPTKMT2A
SCHEMBL10749245 0.72 FTO (0.43) CYP3A4ALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853619-A4 NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS: SYNTHESIS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY UNIV MARYLAND (US) 2009-08-26 EP disclosed
EP-1853619-A1 NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS: SYNTHESIS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY University of Maryland (US) 2007-11-14 EP disclosed
WO-2006093993-A1 NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS: SYNTHESIS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY UNIVERSITY OF MARYLAND (US) 2006-09-08 WO disclosed